Published in Diabetes Care on January 28, 2013
Look AHEAD: Action for Health in Diabetes (LookAHEAD) | NCT00017953
Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care (2014) 1.38
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care (2015) 1.10
Long-term impact of behavioral weight loss intervention on cognitive function. J Gerontol A Biol Sci Med Sci (2014) 0.98
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation (2016) 0.84
Treatment of affective disorders in cardiac disease. Dialogues Clin Neurosci (2015) 0.77
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Curr Atheroscler Rep (2014) 0.76
Relative differences in resting-state brain connectivity associated with long term intensive lifestyle intervention. Psychoneuroendocrinology (2016) 0.75
Antidepressant Use and Subclinical Measures of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis. J Clin Psychopharmacol (2016) 0.75
Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA (2004) 12.13
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials (2003) 9.97
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med (2004) 6.00
Standards of medical care in diabetes. Diabetes Care (2005) 5.98
Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J (2010) 4.31
Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res (2006) 4.30
Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry (2010) 3.96
Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med (2004) 3.94
Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol (2005) 3.92
Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA (2008) 3.55
Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry (2005) 3.41
Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care (2005) 3.13
Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol (2010) 2.68
Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med (2000) 2.62
Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension (2009) 2.58
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care (2007) 2.42
Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care (2003) 2.15
New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med (2010) 2.09
Self-reported distress: analog or Ersatz depression? Psychol Bull (1994) 1.81
Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants. Diabetes Care (2005) 1.70
Depression in diabetes: have we been missing something important? Diabetes Care (2011) 1.51
Weight gain in the treatment of mood disorders. J Clin Psychiatry (2003) 1.42
Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care (2008) 1.41
Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J (2010) 1.24
Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors. Diabetes Care (2008) 1.14
The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications. CNS Drugs (2010) 0.99
Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabetologia (2010) 0.99
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study. BMC Public Health (2011) 0.96
Increased platelet aggregability in major depression? Psychiatry Res (2001) 0.94
Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS). Circulation (2004) 0.85
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials (2003) 9.97
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med (2010) 8.77
Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med (2010) 8.70
The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring) (2006) 8.25
Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med (2005) 8.00
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med (2006) 7.75
Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care (2006) 7.09
Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. JAMA (2003) 7.07
A randomized trial comparing human e-mail counseling, computer-automated tailored counseling, and no counseling in an Internet weight loss program. Arch Intern Med (2006) 5.69
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care (2011) 5.50
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA (2003) 5.26
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol (2013) 5.24
Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA (2012) 5.15
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes (2005) 4.81
Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care (2008) 4.33
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol (2014) 4.30
Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med (2005) 4.24
One-year weight losses in the Look AHEAD study: factors associated with success. Obesity (Silver Spring) (2009) 4.08
The Diabetes Prevention Program: recruitment methods and results. Control Clin Trials (2002) 4.03
Primary care physicians' attitudes about obesity and its treatment. Obes Res (2003) 3.80
Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev (2004) 3.74
Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med (2010) 3.73
Physical activity and weight loss: does prescribing higher physical activity goals improve outcome? Am J Clin Nutr (2003) 3.71
Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet (2002) 3.68
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring) (2011) 3.62
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology (2010) 3.55
A genomewide single-nucleotide-polymorphism panel for Mexican American admixture mapping. Am J Hum Genet (2007) 3.39
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 3.35
Consistent self-monitoring of weight: a key component of successful weight loss maintenance. Obesity (Silver Spring) (2007) 3.30
A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med (2009) 3.27
Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol (2010) 3.17
Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes (2002) 3.14
Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring) (2014) 3.10
A randomized controlled trial of a commercial internet weight loss program. Obes Res (2004) 3.06
Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ (2003) 3.05
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res (2011) 3.01
Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care (2009) 2.95
Seasonal patterns in monthly hemoglobin A1c values. Am J Epidemiol (2005) 2.93
Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med (2012) 2.90
Treatment of obesity in primary care practice in the United States: a systematic review. J Gen Intern Med (2009) 2.89
Fast food consumption and breakfast skipping: predictors of weight gain from adolescence to adulthood in a nationally representative sample. J Adolesc Health (2006) 2.74
A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes (2007) 2.67
Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA (2003) 2.60
National standards for diabetes self-management education. Diabetes Care (2008) 2.60
Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med (2009) 2.59
Randomized trial of a behavioral intervention to prevent excessive gestational weight gain: the Fit for Delivery Study. Am J Clin Nutr (2011) 2.55
The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2009) 2.53
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med (2014) 2.50
Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care (2007) 2.42
Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med (2013) 2.38
National standards for diabetes self-management education. Diabetes Care (2009) 2.36
National standards for diabetes self-management education. Diabetes Care (2012) 2.36
The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care (2012) 2.33
Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. J Sex Med (2009) 2.30
Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative. J Am Geriatr Soc (2012) 2.30
Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. Am J Hum Genet (2002) 2.29
Mexican American ancestry-informative markers: examination of population structure and marker characteristics in European Americans, Mexican Americans, Amerindians and Asians. Hum Genet (2003) 2.27
The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab (2008) 2.27
The Lifestyle Interventions and Independence for Elders Study: design and methods. J Gerontol A Biol Sci Med Sci (2011) 2.26
National standards for diabetes self-management education. Diabetes Care (2007) 2.21
Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring. Diabetes (2006) 2.21
Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes (2011) 2.17
Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol (2003) 2.12
Differential functional magnetic resonance imaging response to food pictures in successful weight-loss maintainers relative to normal-weight and obese controls. Am J Clin Nutr (2009) 2.12
Trial of family and friend support for weight loss in African American adults. Arch Intern Med (2009) 2.10
Association between marijuana exposure and pulmonary function over 20 years. JAMA (2012) 2.09